Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERASE-Aging: Empagliflozin for Arterial Stiffening in Aging
NCT06506422Phase 3Recruiting
- Sponsor
- University of Missouri
- Start
- Aug 2024
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin in arterial stiffness, sponsored by University of Missouri. Started Aug 2024; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
arterial stiffness
Beyond the preview
Go deeper on NCT06506422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06506422.